“…Through these in vivo animal studies, we determined (1) at 6 months, frozen OCA already exhibited clear progression toward failure, with loss of chondrocytes, reduced proteoglycan content and cartilage stiffness, and associated surface and/or bone collapse, while fresh OCA preserved depth-dependent tissue properties similar to non-operated cartilage, and thus maintained their capacity for biological homeostasis 19 ; (2) proteoglycan-4 (PRG4)secreting function of OCA is maintained based on its state at implantation 20 ; (3) frozen OCA show similar changes at 12 months that were evident after 6 months whereas 4˚C stored OCA exhibit reduced performance and variable long-term outcomes which were associated with reduced cellularity at the articular surface versus consistently good repair by fresh OCA 18 ; (4) the presence of bone cysts (void areas diameter greater than 1 mm by mCT) were widespread and bone structure was altered by OCA relative to contralateral non-operated control knees 21 ; and (5) OCA repair patterns all exhibited basal cysts (located near the base of the implant), and occurred (a) in isolation, (b) with subchondral cysts (located near the bone-cartilage interface) and subchondral bone (ScB) channels, (c) with ScB channels, or (d) with subchondral cysts, ScB channels, and ScB erosion suggesting that bone cysts occurring after OCA may result from aberrant mechanobiology. 21 Current MRI grading scales used for cartilage repair or osteoarthritis are not targeted to evaluate OCA repair that have both chondral and osseous components. Thus, we were motivated by the need for non-invasive characterization of OCA and the ability to refine MRI technology to predict clinical outcomes.…”